GlobeNewswire
Trump Media & Technology Group and TAE Technologies Announce Effectiveness of Form S-4 Registration Statement for Proposed Merger
~ Files Definitive Proxy Statement/Prospectus as Combination Moves Toward Shareholder Vote ~ SARASOTA, Fla. and HOUSTON, Nov. 05, 2026 (GLOBE NEWSWI...
Arteris Announces Financial Results for the Third Quarter and Estimated Fourth Quarter and Updated Full Year 2026 Guidance
CAMPBELL, Calif., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Arteris, Inc. (Nasdaq: AIP), a leading provider of semiconductor technology for accelerating inno...
T3 Defense Delivers a UAV Command & Control Center to BlueBird Aero Systems
NEW YORK and NETANYA, Israel, Nov. 05, 2026 (GLOBE NEWSWIRE) -- T3 Defense Inc. (Nasdaq: DFNS) (“T3 Defense” or the “Company”), a defense company tha...
Equillium to Participate in Upcoming Investor Conferences
LA JOLLA, Calif., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a biotechnology innovator developing novel therapies to treat serio...
Organogenesis Holdings Inc. Reports Third Quarter 2026 Financial Results
CANTON, Mass., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine and tissue innovations c...
Larimar Therapeutics Announces Three Poster Presentations for the Nomlabofusp Program at the Upcoming International Congress for Ataxia Research
BALA CYNWYD, Pa., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (Larimar) (Nasdaq: LRMR), a clinical-stage biotechnology company focus...
Aprea Therapeutics to Present at the Guggenheim 3rd Annual Healthcare Innovation Conference
DOYLESTOWN, Pa., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical-stage precision me...
Aeluma to Participate in 2026 Stifel Deep Tech Summit
GOLETA, Calif., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Aeluma, Inc. (NASDAQ: ALMU), a semiconductor company specializing in high-performance, scalable tec...
MacroGenics to Participate in Upcoming Investor Conferences
ROCKVILLE, MD, Nov. 05, 2026 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on developing i...
Solésence To Report Third Quarter 2026 Financial Results and Host a Conference Call on November 12
ROMEOVILLE, Ill., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across be...
Nutanix Announces Date and Conference Call Information for First Quarter Fiscal Year 2027 Financial Results
SAN JOSE, Calif., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Nutanix, Inc. (NASDAQ: NTNX), a hybrid cloud leader and AI platform company, today announced that...
Aligos Therapeutics Presents Positive Data at The Liver Meeting® 2026
SOUTH SAN FRANCISCO, Calif., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company f...